INTRODUCTION: The objective of this study was to estimate the theoretical needs -based on evidence- of radiotherapy treatments (RDT) in Andalusia, compare these needs with actual use of RDT in 2006 and analyse their evolution from 2003. MATERIALS AND METHODS: Correlation between quantitative variables was analysed with Pearson's correlation coefficient. This dealt with differences between administered/estimated treatments and treatments carried out in years with the Student's t-distribution, and the Xi2 test among qualitative variables. RESULTS: In Andalusia, the evidence-based rate of cancer irradiation is 55%. Eighty-five percent of theoretical treatments were administered in 2006. From this group, 107% were in gynaecological tumours, 100% in breast cancer cases, 71% in head and neck cancer and 48% in lung cancers; differences in the last two conditions were significant (p<0.01). As for regional distribution, differences were reported with reference to irradiation rates (p<0.0002) and resource distribution. In the last three years, an increment of 17% was observed in treatments conducted in public hospitals. The rate increased from 61% (with regard to optimal values) to 85% in 2006; in a parallel way, an increment was seen in therapy units (from 22 to 26) and radiation oncologists (from 57 to 69). CONCLUSIONS: Despite the increment of irradiation rates seen in the last years, there is still a serious underutilisation of RDT for some cancer types (lung, head and neck cancer), as well as a great variability in the use of RDT between hospitals.
INTRODUCTION: The objective of this study was to estimate the theoretical needs -based on evidence- of radiotherapy treatments (RDT) in Andalusia, compare these needs with actual use of RDT in 2006 and analyse their evolution from 2003. MATERIALS AND METHODS: Correlation between quantitative variables was analysed with Pearson's correlation coefficient. This dealt with differences between administered/estimated treatments and treatments carried out in years with the Student's t-distribution, and the Xi2 test among qualitative variables. RESULTS: In Andalusia, the evidence-based rate of cancer irradiation is 55%. Eighty-five percent of theoretical treatments were administered in 2006. From this group, 107% were in gynaecological tumours, 100% in breast cancer cases, 71% in head and neck cancer and 48% in lung cancers; differences in the last two conditions were significant (p<0.01). As for regional distribution, differences were reported with reference to irradiation rates (p<0.0002) and resource distribution. In the last three years, an increment of 17% was observed in treatments conducted in public hospitals. The rate increased from 61% (with regard to optimal values) to 85% in 2006; in a parallel way, an increment was seen in therapy units (from 22 to 26) and radiation oncologists (from 57 to 69). CONCLUSIONS: Despite the increment of irradiation rates seen in the last years, there is still a serious underutilisation of RDT for some cancer types (lung, head and neck cancer), as well as a great variability in the use of RDT between hospitals.
Authors: R Esco; A Palacios; J Pardo; A Biete; J A Carceller; C Veiras; G Vazquez Journal: Int J Radiat Oncol Biol Phys Date: 2003-06-01 Impact factor: 7.038
Authors: Leslie K Ballas; Elena B Elkin; Deborah Schrag; Bruce D Minsky; Peter B Bach Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-15 Impact factor: 7.038
Authors: Søren M Bentzen; Germaine Heeren; Brian Cottier; Ben Slotman; Bengt Glimelius; Yolande Lievens; Walter van den Bogaert Journal: Radiother Oncol Date: 2005-03-16 Impact factor: 6.280
Authors: Lydia Voti; Lisa C Richardson; Isildinha M Reis; Lora E Fleming; Jill Mackinnon; Jan Willem W Coebergh Journal: Cancer Date: 2006-01-01 Impact factor: 6.860
Authors: J López-Torrecilla; D González Sanchis; D Granero Cabañero; E García Miragall; P Almendros Blanco; A Hernandez Machancoses; L Brualla González; J Pastor Peidro; J C Gordo Partearroyo; J Rosello Ferrando Journal: Clin Transl Oncol Date: 2021-02-14 Impact factor: 3.405
Authors: José Expósito; Isabel Linares; Isabel Castillo; Miguel Martínez; Pilar Vargas; Ismael Herruzo; José Antonio Medina; Amalia Palacios; Eloísa Bayo; Francisco Peracaula; Javier Jaén; José Antonio Sánchez; María José Ortiz Journal: Radiat Oncol Date: 2015-12-30 Impact factor: 3.481
Authors: Isabel Tovar; Jose Expósito; Javier Jaén; Enrique Alonso; Miguel Martínez; Rosa Guerrero; Juan P Arrebola; Rosario Del Moral Journal: BMC Cancer Date: 2014-09-23 Impact factor: 4.430